PEPTONIC MEDICAL Market Cap ($5.52 Million)
Market Cap & Net Worth: PEPTONIC MEDICAL (28L)
PEPTONIC MEDICAL market cap. PEPTONIC MEDICAL (F:28L) has a market capitalization of $5.52 Million (€4.72 Million) as of November 3, 2026. Listed on the F stock exchange, this Germany-based company holds position #28315 globally and #2432 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying PEPTONIC MEDICAL's stock price €0.00 by its total outstanding shares 27580019985 (27.58 Billion). Also see PEPTONIC MEDICAL operating cash flow efficiency for how efficiently the company converts equity into cash flow.
PEPTONIC MEDICAL Market Cap History (2021–2026)
PEPTONIC MEDICAL market cap history from 2021 to 2026. Data shows change from $1.05 Billion to $6.45 Million (-68.89% CAGR). Check latest PEPTONIC MEDICAL stock price today for real-time trading data and today's change.
PEPTONIC MEDICAL Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how PEPTONIC MEDICAL's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 28L shareholders equity momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.44x
PEPTONIC MEDICAL's market cap is 0.44 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $1.05 Billion | $31.64 Million | -$73.69 Million | 33.22x | N/A |
| 2022 | $222.48 Million | $43.63 Million | -$36.86 Million | 5.10x | N/A |
| 2023 | $135.42 Million | $37.12 Million | -$42.59 Million | 3.65x | N/A |
| 2024 | $6.45 Million | $26.89 Million | -$60.03 Million | 0.24x | N/A |
| 2025 | $6.45 Million | $14.79 Million | -$22.50 Million | 0.44x | N/A |
Competitor Companies of 28L by Market Capitalization
Companies near PEPTONIC MEDICAL in the global market cap rankings as of November 3, 2026. Also see PEPTONIC MEDICAL asset portfolio for a full breakdown of the balance sheet.
Key companies related to PEPTONIC MEDICAL by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #511 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #535 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #593 globally with a market cap of $45.23 Billion USD ( CN¥309.13 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #619 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #511 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #535 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $46.59 |
| #593 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.23 Billion | CN¥48.46 |
| #619 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.30 |
Market Capitalization of PEPTONIC MEDICAL (2021–2026)
Market capitalization of PEPTONIC MEDICAL from 2021 to today. Between 2021 and today, PEPTONIC MEDICAL's market cap moved from $1.05 Billion to $ 6.45 Million, with a yearly change of -68.89%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €6.45 Million | 0.00% |
| 2025 | €6.45 Million | 0.00% |
| 2024 | €6.45 Million | -95.24% |
| 2023 | €135.42 Million | -39.13% |
| 2022 | €222.48 Million | -78.83% |
| 2021 | €1.05 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 2nd, 2026 the market cap of PEPTONIC MEDICAL was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $5.52 Million USD |
| MoneyControl | $5.52 Million USD |
| MarketWatch | $5.52 Million USD |
| marketcap.company | $5.52 Million USD |
| Reuters | $5.52 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About PEPTONIC MEDICAL
PEPTONIC medical AB (publ), a medical technology company, develops and sells intimate self-care products for women. The company offers products under the VagiVital brand, including a moisturizing gel for atrophy; an intimate calming gel for rapid relief of itching and irritation; moisturizing lubricant; a pH-balancing intimate wash/conditioner; self-test kits for diagnosing pre-menopause, menopau… Read more